Revvity Inc. (NYSE:RVTY) Declares $0.07 Quarterly Dividend

Revvity Inc. (NYSE:RVTY) announced a quarterly dividend on Monday, January 26th. Investors of record on Friday, April 17th will be paid a dividend of 0.07 per share on Friday, May 8th. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, April 17th.

Revvity has a payout ratio of 5.1% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Revvity to earn $5.56 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 5.0%.

Revvity Price Performance

NYSE:RVTY traded down $0.12 during trading hours on Tuesday, reaching $114.58. The company had a trading volume of 124,143 shares, compared to its average volume of 1,431,598. The company has a quick ratio of 1.44, a current ratio of 1.75 and a debt-to-equity ratio of 0.36. The stock has a 50-day moving average of $102.65 and a two-hundred day moving average of $95.07. Revvity has a one year low of $81.36 and a one year high of $128.29. The firm has a market capitalization of $12.99 billion, a PE ratio of 57.65, a PEG ratio of 3.56 and a beta of 1.05.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, October 27th. The company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $698.95 million for the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the prior year, the firm earned $1.28 EPS. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. Analysts forecast that Revvity will post 4.94 earnings per share for the current year.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.